Empire Financial Management Company’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-35,000
| Closed | -$263K | – | 200 |
|
|
2024
Q4 | $263K | Sell |
35,000
-24,000
| -41% | -$180K | 0.08% | 176 |
|
|
2024
Q3 | $448K | Hold |
59,000
| – | – | 0.14% | 154 |
|
|
2024
Q2 | $365K | Sell |
59,000
-20,000
| -25% | -$124K | 0.12% | 158 |
|
|
2024
Q1 | $401K | Buy |
79,000
+5,500
| +7% | +$27.9K | 0.13% | 158 |
|
|
2023
Q4 | $440K | Buy |
73,500
+26,000
| +55% | +$156K | 0.17% | 141 |
|
|
2023
Q3 | $336K | Buy |
47,500
+5,000
| +12% | +$35.4K | 0.15% | 148 |
|
|
2023
Q2 | $299K | Buy |
42,500
+12,500
| +42% | +$88K | 0.12% | 165 |
|
|
2023
Q1 | $250K | Buy |
+30,000
| New | +$250K | 0.1% | 178 |
|